TECX Q1 2023 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$920,000

Operating Income

-$25M

Net Income

-$25M

EPS (Diluted)

$-6.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$83M

Total Liabilities

$30M

Stockholders' Equity

$53M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$920,000	-$399,000	-130.6%
Operating Income	-$25M	-$29M	+14.3%
Net Income	-$25M	-$30M	+16.3%